![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLC41A2 |
Gene summary for SLC41A2 |
![]() |
Gene information | Species | Human | Gene symbol | SLC41A2 | Gene ID | 84102 |
Gene name | solute carrier family 41 member 2 | |
Gene Alias | SLC41A1-L1 | |
Cytomap | 12q23.3 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q96JW4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
84102 | SLC41A2 | HTA11_3410_2000001011 | Human | Colorectum | AD | 5.25e-30 | -8.51e-01 | 0.0155 |
84102 | SLC41A2 | HTA11_2951_2000001011 | Human | Colorectum | AD | 1.79e-06 | -9.60e-01 | 0.0216 |
84102 | SLC41A2 | HTA11_3361_2000001011 | Human | Colorectum | AD | 3.52e-07 | -6.34e-01 | -0.1207 |
84102 | SLC41A2 | HTA11_696_2000001011 | Human | Colorectum | AD | 4.74e-14 | -5.53e-01 | -0.1464 |
84102 | SLC41A2 | HTA11_866_2000001011 | Human | Colorectum | AD | 1.23e-04 | -4.17e-01 | -0.1001 |
84102 | SLC41A2 | HTA11_1391_2000001011 | Human | Colorectum | AD | 6.26e-06 | -4.95e-01 | -0.059 |
84102 | SLC41A2 | HTA11_2992_2000001011 | Human | Colorectum | SER | 3.68e-04 | -6.84e-01 | -0.1706 |
84102 | SLC41A2 | HTA11_546_2000001011 | Human | Colorectum | AD | 1.44e-02 | -5.27e-01 | -0.0842 |
84102 | SLC41A2 | HTA11_7862_2000001011 | Human | Colorectum | AD | 1.99e-02 | -4.52e-01 | -0.0179 |
84102 | SLC41A2 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.10e-24 | -7.77e-01 | 0.096 |
84102 | SLC41A2 | HTA11_9408_2000001011 | Human | Colorectum | AD | 9.76e-04 | -9.12e-01 | 0.0451 |
84102 | SLC41A2 | HTA11_8622_2000001021 | Human | Colorectum | SER | 6.46e-05 | -7.47e-01 | 0.0528 |
84102 | SLC41A2 | HTA11_10711_2000001011 | Human | Colorectum | AD | 7.73e-15 | -8.21e-01 | 0.0338 |
84102 | SLC41A2 | HTA11_7696_3000711011 | Human | Colorectum | AD | 5.45e-28 | -8.17e-01 | 0.0674 |
84102 | SLC41A2 | HTA11_6818_2000001011 | Human | Colorectum | AD | 4.34e-07 | -7.56e-01 | 0.0112 |
84102 | SLC41A2 | HTA11_11156_2000001011 | Human | Colorectum | AD | 1.58e-02 | -8.98e-01 | 0.0397 |
84102 | SLC41A2 | HTA11_6818_2000001021 | Human | Colorectum | AD | 4.61e-08 | -6.95e-01 | 0.0588 |
84102 | SLC41A2 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 3.29e-29 | -6.87e-01 | 0.294 |
84102 | SLC41A2 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 1.91e-08 | -5.85e-01 | 0.281 |
84102 | SLC41A2 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 4.24e-32 | -8.62e-01 | 0.3859 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | CRC | ![]() |
Stomach | GC | ![]() |
Stomach | CAG with IM | ![]() |
Stomach | CSG | ![]() |
Stomach | CAG | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:1903830 | Colorectum | FAP | magnesium ion transmembrane transport | 7/2622 | 17/18723 | 5.62e-03 | 3.61e-02 | 7 |
GO:0015693 | Colorectum | FAP | magnesium ion transport | 7/2622 | 18/18723 | 8.10e-03 | 4.77e-02 | 7 |
GO:19038301 | Colorectum | CRC | magnesium ion transmembrane transport | 7/2078 | 17/18723 | 1.46e-03 | 1.57e-02 | 7 |
GO:00156931 | Colorectum | CRC | magnesium ion transport | 7/2078 | 18/18723 | 2.16e-03 | 2.11e-02 | 7 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC41A2 | SNV | Missense_Mutation | c.70N>A | p.Val24Ile | p.V24I | Q96JW4 | protein_coding | deleterious_low_confidence(0.01) | benign(0) | TCGA-AO-A0J8-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD | |
SLC41A2 | SNV | Missense_Mutation | novel | c.1480N>G | p.His494Asp | p.H494D | Q96JW4 | protein_coding | deleterious(0.04) | possibly_damaging(0.871) | TCGA-C5-A1MH-01 | Cervix | cervical & endocervical cancer | Female | >=65 | III/IV | Chemotherapy | cisplatin | PD |
SLC41A2 | SNV | Missense_Mutation | novel | c.644N>T | p.Ala215Val | p.A215V | Q96JW4 | protein_coding | deleterious(0) | probably_damaging(0.96) | TCGA-EA-A3HS-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
SLC41A2 | SNV | Missense_Mutation | c.509N>T | p.Ala170Val | p.A170V | Q96JW4 | protein_coding | deleterious(0.04) | benign(0.153) | TCGA-Q1-A73O-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
SLC41A2 | SNV | Missense_Mutation | c.1183N>T | p.Gly395Cys | p.G395C | Q96JW4 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-3833-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SLC41A2 | SNV | Missense_Mutation | novel | c.1129N>A | p.Leu377Ile | p.L377I | Q96JW4 | protein_coding | deleterious(0.04) | benign(0.039) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLC41A2 | SNV | Missense_Mutation | novel | c.329N>C | p.Asp110Ala | p.D110A | Q96JW4 | protein_coding | deleterious(0.04) | benign(0.398) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
SLC41A2 | SNV | Missense_Mutation | c.448A>G | p.Lys150Glu | p.K150E | Q96JW4 | protein_coding | tolerated(0.38) | benign(0.003) | TCGA-CM-6164-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SLC41A2 | SNV | Missense_Mutation | c.1519N>C | p.Phe507Leu | p.F507L | Q96JW4 | protein_coding | tolerated(0.98) | benign(0) | TCGA-D5-6928-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
SLC41A2 | SNV | Missense_Mutation | rs866165305 | c.1010N>T | p.Gly337Val | p.G337V | Q96JW4 | protein_coding | tolerated(0.5) | possibly_damaging(0.617) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |